Brain zaps may curb meth cravings in small pilot trial
NCT ID NCT04449055
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This small pilot study tested whether a type of brain stimulation called transcranial magnetic stimulation (TMS) could help people with methamphetamine use disorder. Nineteen participants received daily TMS sessions for two weeks, then three times a week for two more weeks, while continuing their usual counseling. The study aimed to see if the approach was practical and if it could reduce cravings, improve mood, and change brain activity linked to addiction.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
19 people
The number who actually took part.
- Started
-
Oct 2020
- Finished
-
Mar 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosed with an active methamphetamine use disorder * Is engaged in psychosocial treatment or articulates a plan to engage in psychosocial treatment for methamphetamine use disorder during the study period * Age 18 to 60 years * Able to consent for treatment and research participation * English-speaking * Receiving care from UIHC's Addiction Medicine service. This includes patients in the Crisis Stabilization Unit, seen by the inpatient consultation service, enrolling in partial hospitalization or intensive outpatient treatment, or seen in the outpatient Addiction Medicine clinics. Exclusion Criteria: * Age less than 18 years * Patients that are excluded during TMS assessment including: patients with epilepsy or seizure disorder, patients with implanted ferromagnetic equipment in their face or skull near the stimulation target. * Current medical treatment with clozapine or stimulants. * Current diagnosis of bipolar disorder, schizoaffective disorder, schizophrenia, that is deemed by research team psychiatrists not to have been drug-induced. Psychotic disorder not associated with drug use per the MINI International Neuropsychiatric Interview. Psychosis NOS, in remission, or drug-induced psychotic episodes are not exclusion criteria since these may be related to methamphetamine misuse. * Lacks the mental capacity to provide informed consent (i.e. not able to demonstrate understanding of the risks and benefits of participation) * Has a court appointed guardian. * Unstable medical illness. * Current diagnosis of neurological disorder or neurocognitive disorder. * Prior neurosurgical procedure. * History of seizure. * History of ECT treatment within the past three months. * History of any previous TMS treatment. * Known inability to complete the protocol, as assessed by asking them if they are able to make it to all visits for this study without assistance. MRI Exclusion criteria: * Implanted device including pacemaker, coronary stent, defibrillator, or neurostimulation device that is not MRI-compatible * Metal in body including bullets, shrapnel, metal slivers * Claustrophobia * Uncontrolled high blood pressure * Atrial fibrillation * Significant heart disease * Hemodynamic instability * Kidney disease * Pregnant
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Addiction, drug are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Iowa
Iowa City, Iowa, 52242, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Meth reduction may lower STI risk, small study suggests
- Hormone therapy shows promise in preventing relapse in postpartum meth users
- Study reveals Meth's impact on hidden HIV
- Could a Naltrexone-Bupropion combo curb meth addiction? new trial seeks answers
- Could a brain drug curb meth addiction?
- New program aims to keep hospital patients on track for opioid and meth recovery